US FDA To Clarify Plausible Mechanism Framework With Genome Editing Guidances, Workshop

 
• By Sue Sutter and Maaisha Osman
  
Genome editing
Two genome editing guidances will help clarify the plausible mechanism pathway. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from United States